Background: Randomised controlled trials have shown a beneficial effect of antihypertensive treatment on stroke recurrence. The effect of antihypertensive treatment on survival and recurrence in an unselected sample of the general population, using the General Practice Research Database, was analysed. Methods: Cox regression estimating the effect of antihypertensive treatment on survival and stroke recurrence >1 year among 44,244 first-ever strokes in the UK from 1997 to 2006 was adjusted by propensity score analysis considering gender, age, general practice, stroke year, drug prescriptions and diagnostic codes from other diseases. Results: The EU standardised stroke incidence was 118 per 100,000 (95% CI = 117–120). The 90-day case fatality was 19%. By 90 days after stroke 20,147 (58%) were diagnosed as having hypertension, of whom 75% had received antihypertensive treatment after stroke. After 5 years 68% of the hypertensive stroke patients receiving antihypertensive treatment were alive, while this proportion for patients not prescribed antihypertensive treatment was 59%. This could not be explained by potential confounders with an adjusted relative risk of 0.62 (95% CI = 0.58–0.66; p < 0.001) for antihypertensive treatment and premature death. The adjusted relative risk of antihypertensive treatment on stroke recurrence after 1 year, which was observed in 35% until 5 years after stroke, was 0.92 (95% CI = 0.84–1.01; p = 0.092). Conclusions: A high proportion of hypertensive stroke patients did not receive antihypertensive treatment. The protective effect of antihypertensive treatment on survival was higher in this general population than reported in randomised controlled trials, while an effect of antihypertensive treatment on late stroke recurrence was borderline, but not significant.

Keywords:
Antihypertensive agents, Hypertension, Cerebrovascular disease
1.
Rashid P, Leonardi-Bee J, Bath P: Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003;34:2741–2748.
2.
Zhang H, Thijs L, Staessen JA: Blood pressure lowering for primary and secondary prevention of stroke. Hypertension 2006;48:187–195.
3.
Intercollegiate Stroke Working Party: National Clinical Guidelines for Stroke. London, Royal College of Physicians of London, 2008.
4.
Williams B, Poulter NR, Brown MJ, et al: British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004;328:634–640.
5.
European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee: Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457–507.
6.
Rothwell PM: External validity of randomised controlled trials: ‘to whom do the results of this trial apply?’ Lancet 2005;365:82–93.
7.
Grol R, Dalhuijsen J, Thomas S, Veld C, Rutten G, Mokkink H: Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ 1998;317:858–861.
8.
Lenfant C: Shattuck lecture – clinical research to clinical practice – lost in translation? N Engl J Med 2003;349:868–874.
9.
Office for National Statistics: Key Health Statistics from General Practice 1998. London, Office for National Statistics, 2000.
10.
Kurth T, Walker AM, Glynn RJ, et al: Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 2006;163:262–270.
11.
Heuschmann PU, Grieve AP, Toschke AM, Rudd AG, Wolfe CD: Ethnic group disparities in 10-year trends in stroke incidence and vascular risk factors: the South London Stroke Register (SLSR). Stroke 2008;39:2204–2210.
12.
PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033–1041.
13.
Grobbee DE, Hoes AW: Confounding and indication for treatment in evaluation of drug treatment for hypertension. BMJ 1997;315:1151–1154.
14.
Bosch J, Yusuf S, Pogue J, et al: Use of ramipril in preventing stroke: double-blind randomised trial. BMJ 2002;324:699–702.
15.
Ramsay LE, Williams B, Johnston GD, et al: British Hypertension Society guidelines for hypertension management 1999: summary. BMJ 1999;319:630–635.
16.
Sever P, Beevers G, Bulpitt C, et al: Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993;306:983–987.
17.
Law MR, Wald NJ, Morris JK, Jordan RE: Value of low-dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003;326:1427.
18.
Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M: Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008;336:1114–1117.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.